FDA applicant

U.S. Drug Testing, Inc.

Rancho Cucamonga, CA6 decisions1993–19940 recalls

FDA records 6 decisions for U.S. Drug Testing, Inc. (Rancho Cucamonga, CA) from 1993 to 1994: 6 510(k) clearances. Most are in product codes DKZ (Enzyme Immunoassay, Amphetamine) and LCM (Enzyme Immunoassay, Phencyclidine). No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical toxicology panel, where it files most

How often FDA has decided U.S. Drug Testing, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

No FDA decision for U.S. Drug Testing, Inc. since 2007.

Recalls per year

No recall linked to its devices since 2007.

FIG. 1 — U.S. Drug Testing, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like U.S. Drug Testing, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

U.S. Drug Testing, Inc.

Which product codes does it file in?

What has FDA decided for it lately?